SciELO - Scientific Electronic Library Online

 
vol.128 issue1Safety and efficacy of celiprolol in patients with chronic obstructive lung diseasePrevalence of delirium in an Intermediate Care Unit author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

BRAGHETTO M, talo et al. Survival of patients with esophageal carcinoma subjected to total thoracic esophagectomy. Rev. méd. Chile [online]. 2000, vol.128, n.1, pp.64-74. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000000100009.

Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal resection between 1985 and 1996. Patients were classified according to the location of the tumor and its staging. Results: Eleven patients died in the immediate postoperative period and 90 patients were followed. In 53 the exact cause of death was determined. Global five years survival was 29% and median survival was 18 months. Survival was 100% in stage I tumors. Adjuvant therapy resulted in a better survival of stage III tumors. Survival of stage IV tumors was worst than stage I to III tumors. There was no survival difference between squamous carcinoma or adenocarcinoma. Tumors located in the superior third of the esophagus had a worst prognosis. Causes of death were mediastinic metastases, local recidivism, pleural or pulmonary metastases and less frequently, brain, bronchial or bone metastases. Conclusions: The survival of these, patients with esophageal carcinoma did not differ from the figures reported abroad. (Rev Méd Chile 2000; 128: 64-74)

Keywords : Esophageal neoplasms; Neoplasm staging; Surgery, operative.

        · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License